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DOI 10.1016/j.stem.2009.08.001Mouse and human somatic cells can be
reprogrammed to induced pluripotent
stem cells (iPSCs) by the transduction of
four transcription factors, Oct 3/4, Sox2,
Klf4, and c-Myc (Maherali et al., 2007;
Meissner et al., 2007; Okita et al., 2007;
Takahashi et al., 2007; Takahashi and
Yamanaka, 2006; Wernig et al., 2007).
Patient or disease-specific human iPSCs
could be used for studying pathogenesis,
or potentially also to treat patients
suffering from incurablediseasesby trans-
planting the regenerated grafts derived
from their own cells. However, the low
induction efficiency and high tumorigen-
esis rate due to the use of proto-onco-
genes, such as c-Myc, continue to hinder
the clinical application of iPS technology.
Many efforts have been made to find
other factors or small molecules that
facilitate the reprogramming process
(Huangfu et al., 2008; Shi et al., 2008b).
In this study, we show that conducting
reprogramming in hypoxic conditions re-
sults in improved efficiency for both
mouse and human cells.
Somatic stem cells reside in specific
microenvironments, called niches, and
environmental changes, such as stromal
cell contacts, extracellular matrix pro-
teins, temperature, and O2 tension, have
a great influence on stem cell function
and differentiation. Notably, low O2
tension promotes the survival of neural
crest cells and hematopoietic stem cells
and prevents differentiation of human
ESCs (Danet et al., 2003; Ezashi et al.,
2005; Morrison et al., 2000). Moreover,
mammalian embryonic epiblasts reside
in a physiologically hypoxic environment.
These observations led us to the hypoth-
esis that hypoxic conditions might pro-
mote the reprogramming process and
thus iPS cell generation.
To quantify the effect of hypoxia on iPS
cell generation, we performed compar-ison experiments on mouse embryonic
fibroblasts (MEFs) carrying the Nanog-
GFP-Ires-Puror cassette (Okita et al.,
2007). Four or three transcription factors
(Oct3/4, Sox2, Klf4, +/ c-Myc) were
introduced into MEFs with retroviral
vectors. Four days after transduction,
the cells were trypsinized and seeded
onto the feeder layer of mitomycin
C-treated STO cells. The cells were culti-
vated under 21%, 5%, or 1% O2 from
day 5 to day 14 after transduction. GFP+
iPS cell colonies could be first detected
on days 10–14 after viral transduction,
and we counted the number of GFP-posi-
tive colonies on days 21 and 28 after
transduction. Under 5% O2, the GFP-
positive colonies derived from four-factor
transduced MEFs increased 7.4-fold on
day 21 and 3.1-fold on day 28, and those
from three-factor transduced MEFs
increased 20-fold on day 21 and 7.6-fold
on day 28 under 5% O2 (Figures 1Aa
and 1Ab). Moreover, hypoxic treatment
increased the percentage of GFP-positive
colonies in total colonies from four- or
three-factor transduced MEFs (Figures
1Ac and 1Ad). The GFP-positive colonies
derived after hypoxic treatment was
comparable in morphology and size to
those derived under normoxic conditions
(Figure S1 available online). Alkaline phos-
phatase staining showed that cultivation
under 5% O2 increased the number of
colonies with a positive alkaline phospha-
tase activity (Figure S2). We also exam-
ined whether GFP-positive cells were
detected more quickly under hypoxic
conditions. The four-factor transduced
MEFs were cultivated under 21% O2 or
under 5% O2 with or without VPA from
day 5 to day 9 after transduction and
were subjected to flow cytometric anal-
ysis on day 9. Retroviral expression of
four factors induced 0.01% of the cells
to become GFP-positive on day 9 afterCell Stem Cell 5,transduction. Treating the four-factor
transduced MEFs for 4 days with hypoxia
or with VPA increased the percentage
of GFP-positive cells to 0.40% and
0.48%, respectively. Moreover, cotreat-
ment with hypoxia and VPA increased
the percentage of GFP-positive cells to
2.28%. These data suggest that GFP-
positive cells can be detected earlier and
that the effect of hypoxic culture syner-
gizes with VPA (Figures 1Ba–1Bd).
Although neural stem cells that express
SOX2 endogenously can be reprog-
rammed to iPS cells with the transduction
of Oct3/4 and Klf4 (Kim et al., 2008), the
reprogramming ofMEFs to iPS cells rarely
occurs with two transcription factors of
Oct3/4 and Klf4. Recently, small-mole-
cule compounds have been reported to
enable the reprogramming of Oct3/4 and
Klf4-transduced MEFs to iPS cells (Shi
et al., 2008a). We examined whether
hypoxic conditions could enhance MEFs
to be reprogrammed to iPS cells with
Oct3/4 and Klf4 transduction. Figure 1Ae
shows an increased efficiency of the iPS
cell generation derived from MEFs with
Oct3/4 and Klf4 (MEF-2F-iPS) under 5%
O2 in comparison to 21% O2.
To further evaluate the pluripotency
of the iPS cells generated with hypoxic
treatment, we randomly picked up and
established multiple iPS cell lines from
two-, three-, and four-factor-infected
MEFs. These iPS cells exhibited typical
ES cell morphology. We examined the
karyotype of iPS cell lines derived after
hypoxic treatment (521AH5-1 and
527CH5-1), and these cell lines showed
normal karyotypes (Figure S3).We investi-
gated the mRNA expression of pluripo-
tency-related genes in the iPS cells gener-
ated after hypoxic treatments. The mRNA
expression patterns of these iPS cells
were comparable to those of ESCs
(Figure S4). When injected into nudeSeptember 4, 2009 ª2009 Elsevier Inc. 237
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Figure 1. Hypoxia Promotes Reprogramming of Mouse Embryonic Fibroblasts to iPS Cells
(Aa–Ad) Counts of the Nanog-GFP-positive colonies from four-factor-transduced MEFs on day 21 (white)
and on day 28 (black) (Aa), from three-factor transducedMEFs on day 21 (white) and on day 28 (black) (Ab).
The percentage of GFP-positive colonies in total colonies from four-factor-transduced MEFs (Ac) and
three-factor-transduced MEFs (Ad) on day 21.
(Ae) Counts of Nanog-GFP-positive colonies fromOct3/4 and Klf4-transducedMEFs on day 28. The aver-
ages and standard deviations of four experiments are shown. *p < 0.05 versus 21% O2, **p < 0.01 versus
21% O2.
(B) Percentage of GFP-positive cells from four-factor-transducedMEFs on day 9 cultivated under hypoxic
and normoxic conditions with and without VPA. Representative flow cytometric analysis of four-factor-
transduced MEFs under 21% O2 (Ba) and 5% (Bb) without VPA, and under 21% O2 (Bc) and under 5%
(Bd) with VPA. The signal from the PE channel was used as a control for autofluorescence. The averages
and standard deviations of three independent experiments are shown. *p < 0.05 versus 21% O2 without
VPA, **p < 0.0001 versus 21% O2 with VPA. p < 0.0001 versus 5% O2 without VPA.
(C) The iPS cells derived from two-factor-transduced MEFs gave rise to chimeric mice with a cinnamon
coat color in contrast to wild-type ICR mice. Chimeric mouse from MEF-2F-iPS (Ca) and wild-type ICR
mouse (Cb).
(D) MEFs were transiently transfected with expression plasmids of reprogramming factors and cultivated
under hypoxic and normoxic conditions. On day 25, the number of GFP-positive colonies was counted.
Counts of the Nanog-GFP-positive colonies from six experiments were plotted. *p < 0.05 versus 21% O2.238 Cell Stem Cell 5, September 4, 2009 ª2009 Elsevier Inc.mice subcutaneously, all of the estab-
lished iPS cell lines gave rise to teratomas
with histologic evidence of cells differenti-
ating into all three germ layers (Figure S5).
Moreover, MEF-2F-iPS cells derived
under hypoxic conditions contributed to
the formation of somatic tissue in chimeric
mice (Figures 1Ca and 1Cb), but we have
not yet obtained germline transmission
with these mice, so the extent of reprog-
ramming is not entirely clear. Previous
studies have shown that iPSCs generated
with the same three or four factors are
capable of germline transmission (Naka-
gawa et al., 2008; Okita et al., 2007).
Recently, it was reported that iPS
cells could be established by other
methods than retroviruses or lentiviruses.
We reported that transient transfection
of expression plasmid vectors of four
reprogramming factors could reprogram
MEFs to iPS cells (Okita et al., 2008). It
was also reported that MEFs could be
reprogrammed by transcription factors
delivered by piggyBac (PB) transposition
system (Kaji et al., 2009; Woltjen
et al., 2009). The PB insertions can
be removed from established iPS cells.
These methods minimize the potential for
insertional mutagenesis. We examined
whether hypoxia could improve the effi-
ciency of iPS cell generation with plasmid
vectors and with PB transposition system.
Figure 1D shows that hypoxic cultivation
significantly increased the number of
GFP-positivecolonieswith transient trans-
fection of plasmid vectors, and Figure 1E
shows that hypoxic treatment for 5 and
10 days increased the number of GFP-
positive colonies with the piggyBac trans-
position system by 2.9-fold and 4.0-fold,
respectively. These data suggest that
hypoxia can increase the efficiency of iPS
cell generation by nonviral vectors such
as plasmid expression vectors or the pig-
gyBac transposition system.
We next examined the effect of hypoxic
culture on proliferation, survival, and gene
expression. Flow cytometric analysis with
annexin V demonstrated that hypoxic
culture had no protective effect on mouse
(E) MEFs were reprogrammed with doxycycline-
inducible transcription factors delivered by PB
transposition. The cells were cultivated under
hypoxic or normoxic conditions. Counts of the
Nanog-GFP-positive colonies on day 12 were
shown. The averages and standard deviations of
three experiments are shown. *p < 0.01 versus
21% O2, ** p < 0.001 versus 21%O2.
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Figure 2. Hypoxia Increases the Efficiency of iPS Cell Generation from Human Dermal Fibroblasts
(A) Time schedules of human iPS cell generation from HDFs.
(B) The number of human ESC-like colonies on day 24 (Ba), on day 32 (Bb), and on day 40 (Bc). The averages and standard deviations of three experiments are
shown. *p < 0.01 versus 21% O2; **p < 0.05 versus 21% O2.
(C) Representative phase contrast image of human ESC-like colonies (Ca) and alkaline phosphatase staining of the established iPS clone generated under 5%O2
(Cb). Immunohistochemical staining of undifferentiated human iPS cells generated under hypoxic conditions is shown in the following subpanels: Nanog (Cc),
SSEA3 (Cd), and SSEA4 (Ce). Immunohistochemical staining of three germ layer markers in the differentiated human iPS cells generated under hypoxic condi-
tions is shown in the following subpanels: Alpha-fetoprotein (Cf), alpha-smooth muscle actin (Cg), glial fibrillary acidic protein (Ch), and beta-3 tubulin (Ci). Scale
bars represent 100 mm.
(D) Semiquantative RT-PCR analysis of ESC-marker genes in human iPS cells generated under normoxic and hypoxic conditions and human ESCs (hES3).
(E) Teratoma formation of human iPS cells generated under hypoxic conditions. Neural epithelium (Ea), pigmented retinal epithelium (Eb), bone-like structure (Ec),
smooth muscle cells (Ed), endodermal epithelium (Ee) are shown. Scale bars represent 100 mm.Cell Stem Cell 5, September 4, 2009 ª2009 Elsevier Inc. 239
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(Figure S6). Furthermore, hypoxic cultiva-
tion showed no effect on proliferation
of mouse ESCs (Figure S7). Although
hypoxic incubation from day 1 to day 4
after transduction had no significant
effect on proliferation of mock-trans-
duced MEFs, it had significant effect on
four-factor-transduced MEFs (Figure S8).
To investigate the expression profile of
cells in reprogramming process, we per-
formed microarray analysis and quantita-
tive real-time RT-PCR. We examined the
expression profile of MEFs cultivated
under hypoxic and normoxic conditions
for 10 days. Microarray analysis shows
that 57.2% of ESC-specific genes were
upregulated and 67.5% of MEF-specific
genes were downregulated in the MEFs
cultivated under 5%O2 (Figures S9A and
S9B). In Figures S9C and S9D, microarray
analysis of four-factor-transduced MEFs
cultivated under hypoxic and normoxic
conditions from day 1 to day 4 showed
that 73.2% of ESC-specific genes (765
genes out of 1045 total genes) were upre-
gulated and 85.8%ofMEF-specific genes
(980 genes out of 1142 total genes) were
downregulated in the cells treated with
hypoxia. Moreover, quantitative real-time
RT-PCR analysis demonstrated that
expression of endogenous Oct3/4 and
Nanog increased 3.4-fold and 2.1-fold,
respectively, in four-factor-transduced
MEFs after 3 days of hypoxic treatment
(Figures S9E and S9F).
To rule out the possibility that hypoxia
enhances iPS cell generation by stimu-
lating STO cells, we examined growth
situation of iPS cells under hypoxic culti-
vation without the feeder layer of STO
cells. Figure S10 shows that cultivation
under 5%O2 increased the number of
GFP-positive colonies, suggesting that
hypoxic enhancement of reprogramming
was not mediated by STO cells.
We next examined whether the expo-
sure to hypoxia increases the efficiency
of iPS cell generation fromhuman somatic
cells. The four transcription factors were
introduced into adult human dermal fibro-
blasts (HDFs) by retroviral vectors. At six
days after transduction, the cells were
trypsinized and seeded onto the feeder
layer of mitomycin C-treated STO cells.
The cells were cultivated under 5% O2
for 7 (1w), 14 (2w), 21 (3w), or 33 days
(Long), and the number of human ESC-
like colonies was counted on day 24, 32,240 Cell Stem Cell 5, September 4, 2009 ª20and 40 after transduction (Figure 2A).
Figure 2B shows that 14 day and 21 day
hypoxic cultivation increased the effi-
ciency of iPS cell generation by 4.2-fold
and 3.6-fold on day 24, by 2.8-fold and
3.0-fold on day 32, and by 2.6-fold and
2.5-fold on day 40, respectively. We
randomly selected and established
several clones of human iPS cells derived
under hypoxic conditions. All of the
human iPS cell lines had a typical ESC
morphology and were strongly positive
for alkaline phosphatase while also ex-
pressingpluripotent-relatedgenemarkers
(Figures 2Ca, 2Cb, and 2D). Moreover,
immunocytological staining showed that
all of the cell lines expressed SSEA3,
SSEA4, and Nanog (Figures 2Cc–2Ce).
To investigate the differentiation ability
of the human iPS cells derived under
hypoxic conditions, we used floating culti-
vation to form embryoid bodies (EBs).
After 8 days, the iPS cells formed round
embryoid bodies and we then transferred
the EBs to gelatin-coated plates and culti-
vated them for another 8 days. Immuno-
cytochemical analysis showed that for all
the iPS cell lines, attached cells derived
from the EBs were positive for alpha-
fetoprotein (endoderm), alpha-smooth
muscle actin (mesoderm), glial fibrillary
acidic protein (ectoderm), and beta-3
tubulin (ectoderm) (Figures 2Cf–2Ci). To
evaluate pluripotency in vivo, we trans-
planted the human iPS cells into the
testes of SCID mice. All of the established
human iPS cell lines derived after hypoxic
treatment developed teratomas and the
histological study showed the cells in the
teratomas to differentiate into tissues rep-
resenting all three germ layers (Figure 2E).
Although hypoxic conditions promote
reprogramming, hypoxia also induces
cytotoxicity. There are significant differ-
ences between cell types in terms of their
susceptibility to hypoxia. In our experi-
ments, HDFs were more susceptible to
hypoxic cytotoxicity than MEFs. Cultiva-
tion under 1% O2 inhibited the prolifera-
tion of HDFs and even led cell death
within several days, whereas cultivation
under 1% O2 had little effect on the prolif-
eration of MEFs. In our experiments,
hypoxic cultivation showed no significant
effects on the survival of mouse ESCs
and four-factor-transduced cells or on
the proliferation of mouse ESCs and
mock-transduced MEFs. However, in
four-factor-transduced MEFs, hypoxia09 Elsevier Inc.showed a significant proliferative effect
and increased the expression level of
Oct3/4 and Nanog. In addition, exposure
of MEFs to hypoxic conditions shifted
the overall gene expression pattern
toward that of ESCs. Although there may
be several explanations for the positive
effect of hypoxia on the efficiency of
reprogramming, these results suggest
that hypoxic conditions may contribute
to the reprogramming process itself.
In this study, we created hypoxic condi-
tions by flushing hypoxic gas mixture,
by using Forma Series II Universal CO2
incubators (Thermo Scientific), in which
mild hypoxia (5%–6% O2) in a gas phase
can be achieved within 10 min after
opening and closing of the door. However,
because we changed the medium in
a laminar flow hood under normoxic
atmosphere, there must have been some
fluctuation in O2 content after medium
change. More strict control of hypoxia,
with a closed hypoxia workstation or
medium pre-equilibrated under hypoxic
conditions, might further increase the effi-
ciency of iPS cell generation.
In summary, by comparing the effi-
ciency of iPS cell induction under nor-
moxicandhypoxicconditions,weshowed
that hypoxic conditions can improve the
efficiency of iPS cell generation from
mouse and human somatic cells. We
have found that cultivation under 5% O2
favors more efficient iPSC generation,
but further characterization is needed to
determine the optimal O2 concentration
and duration of hypoxic culture for pro-
moting reprogramming process. Ulti-
mately, we hope that understanding the
basis of this effect of hypoxia will
contribute to ongoing efforts to devise
a method for efficient iPSC that does not
require genetic modification.
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